Solasia Pharma reports Japan half-year loss Y579.00M
For Japan half-year ended June 30, Solasia Pharma KK posted revenue of Y8.00 mln and pretax profit loss of Y579.00 mln, versus Y555.00 mln in 2025. Operating loss was Y570.00 mln.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.